The European Medicines Agency (EMA) has granted Merck’s antiviral Covid-19 pill emergency use for EU nations.
The EMA has also started reviewing Pfizer’s antiviral treatment as cases rise across Europe.
The EMA said that while the Merck pill has not yet been been approved, it had issued advice so that nations in the EU could use it.
“The medicine, which is currently not authorised in the EU, can be used to treat adults with Covid-19 who do not require supplemental oxygen and who are at increased risk of developing severe Covid-19,” the EMA said in a statement.
“EMA issued this advice to support national authorities who may decide on possible early use of the medicine prior to marketing authorisation, for example in emergency use settings, in light of rising rates of infection and deaths due to Covid-19 across the EU.”
The pill should not be used by pregnant women or women who are not using contraception and could get pregnant.